These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 35189759)

  • 1. Sudan Black B treatment uncovers the distribution of angiotensin-converting enzyme2 in nociceptors.
    Su S; Yu N; Zhang H; Wu D; Cui H; Ma C
    Mol Pain; 2022; 18():17448069221080305. PubMed ID: 35189759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACE2 and SCARF expression in human dorsal root ganglion nociceptors: implications for SARS-CoV-2 virus neurological effects.
    Shiers S; Ray PR; Wangzhou A; Sankaranarayanan I; Tatsui CE; Rhines LD; Li Y; Uhelski ML; Dougherty PM; Price TJ
    Pain; 2020 Nov; 161(11):2494-2501. PubMed ID: 32826754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.
    Sharma RK; Stevens BR; Obukhov AG; Grant MB; Oudit GY; Li Q; Richards EM; Pepine CJ; Raizada MK
    Hypertension; 2020 Sep; 76(3):651-661. PubMed ID: 32783758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.
    Ni W; Yang X; Yang D; Bao J; Li R; Xiao Y; Hou C; Wang H; Liu J; Yang D; Xu Y; Cao Z; Gao Z
    Crit Care; 2020 Jul; 24(1):422. PubMed ID: 32660650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor.
    Li Y; Zhou W; Yang L; You R
    Pharmacol Res; 2020 Jul; 157():104833. PubMed ID: 32302706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.
    Verdecchia P; Cavallini C; Spanevello A; Angeli F
    Eur J Intern Med; 2020 Jun; 76():14-20. PubMed ID: 32336612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor: Therapeutic Implications.
    Davidson AM; Wysocki J; Batlle D
    Hypertension; 2020 Nov; 76(5):1339-1349. PubMed ID: 32851855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
    Datta PK; Liu F; Fischer T; Rappaport J; Qin X
    Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19.
    Kai H; Kai M
    Hypertens Res; 2020 Jul; 43(7):648-654. PubMed ID: 32341442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship Between COVID-19 and Angiotensin-Converting Enzyme 2: A Scoping Review.
    Shojaee A; Vahedian-Azimi A; Faizi F; Rahimi-Bashar F; Shahriary A; Galeh HEG; Nehrir B; Guest PC; Sahebkar A
    Adv Exp Med Biol; 2021; 1321():53-68. PubMed ID: 33656713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine aspects of ACE2 regulation: RAAS, steroid hormones and SARS-CoV-2.
    Young MJ; Clyne CD; Chapman KE
    J Endocrinol; 2020 Nov; 247(2):R45-R62. PubMed ID: 32966970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
    Cheng H; Wang Y; Wang GQ
    J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
    Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections.
    Speth RC
    Drug Dev Res; 2020 Sep; 81(6):643-646. PubMed ID: 32304146
    [No Abstract]   [Full Text] [Related]  

  • 15. Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: A closer look at angiotensin-converting enzyme 2 (ACE2).
    Zemlin AE; Wiese OJ
    Ann Clin Biochem; 2020 Sep; 57(5):339-350. PubMed ID: 32369402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship Between ACE2 and Other Components of the Renin-Angiotensin System.
    Cohen JB; Hanff TC; Bress AP; South AM
    Curr Hypertens Rep; 2020 Jun; 22(7):44. PubMed ID: 32591908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
    Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z
    Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2.
    Barker H; Parkkila S
    PLoS One; 2020; 15(10):e0240647. PubMed ID: 33112891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of the Renin-Angiotensin-Aldosterone System (RAA) in Patients Infected with SARS-CoV-2-Possible Clinical Consequences.
    Dettlaff-Pokora A; Swierczynski J
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities.
    Zamorano Cuervo N; Grandvaux N
    Elife; 2020 Nov; 9():. PubMed ID: 33164751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.